Elevated serum C‐reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non‐small cell lung cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1743-7563|11|4|e22-e30

ISSN： 1743-7555

Source： ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol.11, Iss.4, 2015-12, pp. : e22-e30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Elevated Serum Sialyl Lewis X-i Antigen Levels in Non-Small Cell Lung Cancer with Lung Metastasis

By  

Respiration, Vol. 65, Iss. 4, 1998-09 ,pp. : 295-298

Karger

Access to resources Recommend Favorite

Immunohistochemical Expression and Serum Levels of CD44 as Prognostic Indicators in Patients with Non-Small Cell Lung Cancer

By  

Oncology, Vol. 90, Iss. 6, 2016-05 ,pp. : 327-338

Karger

Access to resources Recommend Favorite

Clinical Significance of Pretreatment C-Reactive Protein in Patients with Advanced Nonsquamous, Non-Small Cell Lung Cancer Who Received Gefitinib

By  

Oncology, Vol. 79, Iss. 5-6, 2011-03 ,pp. : 355-362

Karger

Access to resources Recommend Favorite

Correlation of C-Reactive Protein with Survival and Radiographic Response to First-Line Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 31, Iss. 12, 2008-11 ,pp. : 665-670

Karger

Access to resources Recommend Favorite

Predictive and Prognostic Value of Early Disease Progression by PET Evaluation in Advanced Non-Small Cell Lung Cancer

By  

Oncology, Vol. 92, Iss. 1, 2016-11 ,pp. : 39-47

Karger

Access to resources Recommend Favorite